Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Personal Assistant What is This Site Help Center Crisis
Powered By

Top 3 search results for "Keytruda" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Early Signs and Symptoms of Lymphocyte-Rich Hodgkin Lymphoma
... Spelled out, ABVD includes the medications: Doxorubicin (Adriamycin or Rubex) Bleomycin (Blenoxane) Vinblastine (Velbane) Dacarbazine (DTIC-Dome) Newer drugs that can also be used include: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Brentuximab (Adcetris) In cases that are more difficult to treat, a person with LRHL may undergo a stem cell transplant ...
Early Signs and Symptoms of Lymphocyte-Rich Hodgkin Lymphoma
... Spelled out, ABVD includes the medications: Doxorubicin (Adriamycin or Rubex) Bleomycin (Blenoxane) Vinblastine (Velbane) Dacarbazine (DTIC-Dome) Newer drugs that can also be used include: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Brentuximab (Adcetris) In cases that are more difficult to treat, a person with LRHL may undergo a stem cell transplant ...
Immunotherapy for Lymphoma: 4 Points To Know
... Examples include: Nivolumab (Opdivo) — Approved for some people with Hodgkin lymphoma Pembrolizumab (Keytruda) — Used to treat some cases of Hodgkin lymphoma Another immunomodulator is the R2 regimen, which combines lenalidomide (Revlimid) with rituximab. Lenalidomide helps boost immune cell activity, while rituximab targets B-cell lymphoma cells. ...
Immunotherapy for Lymphoma: 4 Points To Know
... Examples include: Nivolumab (Opdivo) — Approved for some people with Hodgkin lymphoma Pembrolizumab (Keytruda) — Used to treat some cases of Hodgkin lymphoma Another immunomodulator is the R2 regimen, which combines lenalidomide (Revlimid) with rituximab. Lenalidomide helps boost immune cell activity, while rituximab targets B-cell lymphoma cells. ...
Hodgkin Lymphoma Treatment: What You Need To Know
... Two immunotherapy medications, Keytruda (pembrolizumab) and Opdivo (nivolumab), are often used. These drugs are approved by the U.S. Food and Drug Administration (FDA) to treat cHL that has relapsed or is refractory (resistant to treatment). ...
Hodgkin Lymphoma Treatment: What You Need To Know
... Two immunotherapy medications, Keytruda (pembrolizumab) and Opdivo (nivolumab), are often used. These drugs are approved by the U.S. Food and Drug Administration (FDA) to treat cHL that has relapsed or is refractory (resistant to treatment). ...